Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Cell Transplant Recipient”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Not applicableUnknownNCT04281797
What this trial is testing

Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients

Who this might be right for
Transplantation InfectionKidney Transplant; ComplicationsStem Cell Transplant Complications+2 more
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 90
Testing effectiveness (Phase 2)Looking for participantsNCT05086003
What this trial is testing

Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction

Who this might be right for
Renal Transplantation
Rabin Medical Center 20
Not applicableLooking for participantsNCT05866302
What this trial is testing

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Who this might be right for
Chronic Lung DiseaseHematopoietic Cell TransplantationGraft Versus Host Disease
University of Michigan Rogel Cancer Center 375
Testing effectiveness (Phase 2)Ended earlyNCT00602446
What this trial is testing

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerIron OverloadLeukemia+5 more
Masonic Cancer Center, University of Minnesota 4
Testing effectiveness (Phase 2)WithdrawnNCT03328936
What this trial is testing

Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant

Who this might be right for
Hematopoietic Cell Transplantation RecipientRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Ohio State University Comprehensive Cancer Center
Not applicableLooking for participantsNCT05550298
What this trial is testing

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Who this might be right for
Hematopoietic Cell TransplantSolid Organ TransplantRespiratory Viral Infection
Arkansas Children's Hospital Research Institute 2,000
Testing effectiveness (Phase 2)Study completedNCT01273207
What this trial is testing

Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

Who this might be right for
Bronchiolitis ObliteransConstructive BronchiolitisGraft Versus Host Disease+3 more
National Heart, Lung, and Blood Institute (NHLBI) 7
Testing effectiveness (Phase 2)Study completedNCT01665677
What this trial is testing

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host Disease
Mehdi Hamadani 69
Testing effectiveness (Phase 2)Study completedNCT03179761
What this trial is testing

High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

Who this might be right for
Hematopoietic Cell Transplantation
Vanderbilt-Ingram Cancer Center 124
Post-approval studies (Phase 4)Active Not RecruitingNCT03023631
What this trial is testing

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT03583424
What this trial is testing

Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Hematopoietic Cell Transplantation RecipientRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+9 more
Ohio State University Comprehensive Cancer Center 19
Not applicableWithdrawnNCT02451462
What this trial is testing

Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients

Who this might be right for
Hematopoietic Stem Cell TransplantBone Marrow Transplant
Stanford University
Early research (Phase 1)Study completedNCT01822509
What this trial is testing

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic Leukemia+8 more
National Cancer Institute (NCI) 71
Large-scale testing (Phase 3)Looking for participantsNCT07583888
What this trial is testing

VABu Conditioning in Elderly AML HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientAcute Myeloid Leukemia (AML)
The First Affiliated Hospital of Soochow University 20
Not applicableUnknownNCT05649371
What this trial is testing

Multiphasic Prehab Allo-HSCT

Who this might be right for
Leukemia
University of Calgary 60
Not applicableLooking for participantsNCT06639854
What this trial is testing

The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients

Who this might be right for
Cytomegalovirus Cell Mediated ImmunityHematopoietic Cell Transplant
M.D. Anderson Cancer Center 105
Not applicableStudy completedNCT03642977
What this trial is testing

DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Hematopietic Stem Cell TransplantationBlood ViromeRNA Virus Infections+1 more
University Hospital, Geneva 112
Testing effectiveness (Phase 2)Ended earlyNCT03327727
What this trial is testing

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

Who this might be right for
Invasive AspergillosisInvasive Pulmonary Aspergillosis
Vical 4
Large-scale testing (Phase 3)Study completedNCT02927067
What this trial is testing

Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Who this might be right for
Cytomegalovirus (CMV)
Shire 553
Testing effectiveness (Phase 2)Ended earlyNCT04056611
What this trial is testing

Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Sciences Ireland UC 3
Load More Results